About this trial
We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients, and clarify the effects of sleep hygiene on disease progression and life prognosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects with COPD or IPF.
Disqualifiers
Subjects who have been hospitalized for exacerbation of respiratory failure within 1 month of study participation
Subjects who have already been diagnosed with sarcopenia or cognitive dysfunction
Subjects receiving long-term oxygen therapy (LTOT) or non-invasive ventilation therapy (NIV)
Subjects with obstructive sleep apnea who are indicated for continuous positive airway pressure (CPAP)
Trial population
Patients with COPD or IPF
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Relationship between sleep time at study enrollment and onset of sarcopenia during follow-up period
Secondary outcomes
Relationship between sleep time at study enrollment and the onset of mild cognitive impairment during follow-up period
Relationship between sleep efficiency, arousal at the time of study enrollment and the onset of sarcopenia and mild cognitive impairment during the follow-up period
Association of sleep time, sleep efficiency, arousal at the time of study enrollment and hospitalization and death due to COPD exacerbations or IPF exacerbations during follow-up period
Relationship between sleep time, sleep efficiency, arousal at the time of study enrollment and changes in grip strength, walking speed, skeletal muscle mass and cognitive function during follow-up period
Sponsors and contacts
Click on the lead sponsor to view all of their trials.